Search Within

Matthew Galsky

Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
  3. Book Section (4)
  4. Book Whole (1)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (20)
  3. Genitourinary Oncology Service (18)
  4. Nursing (8)
  5. Epidemiology and Biostatistics (5)
  6. Surgery (5)

More Groups

People
  1. Dean Bajorin (9)
  2. Howard Scher (8)
  3. William Kelly (8)
  4. Joseph Scattergood (5)
  5. Mary Boyle (5)
  6. Svetlana Mironov (5)

More People

Years
  1. 2021 (1)
  2. 2016 (1)
  3. 2008 (1)
  4. 2007 (5)
  5. 2006 (6)
  6. 2005 (10)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer (3)
  3. Urology (2)
  4. Annals of Oncology (1)
  5. Clinical Cancer Research (1)
  6. Comprehensive Textbook of Genitourinary Oncology. 3rd ed (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (3)
  3. Wiley Blackwell (3)
  4. Elsevier Science, Inc. (2)
  5. Oxford University Press (2)
  6. Springer Verlag (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer
    Journal Article

    Galsky, M. D.; Small, E. J.; Oh, W. K.; Chen, I.; Smith, D. C.; Colevas, A. D.; Martone, L.; Curley, T.; Delacruz, A.; Scher, H. I.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Bladder cancer "adjuvant-lite": Tastes great (works as well) and less filling (less toxic)?
    Journal Article

    Galsky, M. D.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The integration of chemotherapy and surgery for bladder cancer
    Journal Article

    Galsky, M. D.; Herr, H. W.; Bajorin, D. F.
    Journal of the National Comprehensive Cancer Network (2005)

    Fulltext@MSK | Save
  • The role of taxanes in the management of bladder cancer
    Journal Article

    Galsky, M. D.
    The Oncologist (2005)

    Fulltext@MSK | Save
  • Response to second-line taxane-based therapy after first-line epothilone B analogue BMS-247550 (BMS) therapy in hormone refractory prostate cancer (HRPC)
    Meeting Abstract

    Rosenberg, J. E.; Galsky, M. D.; Weinberg, V.; Kelly, W. K.; Small, E. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castratemetastatic prostate cancer (PCMPC): Updated results
    Meeting Abstract

    Kelly, W. K.; Galsky, M. D.; Small, E. J.; Oh, W.; Chen, I.; Smith, D.; Martone, L.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • The development of differentiation agents for the treatment of prostate cancer
    Journal Article

    Galsky, M.; Kelly, W. K.
    Seminars in Oncology (2003)

    Fulltext@MSK | Save
  • Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration
    Journal Article

    Smaletz, O.; Galsky, M.; Scher, H. I.; Delacruz, A.; Slovin, S. F.; Morris, M. J.; Solit, D. B.; Davar, U.; Schwartz, L.; Kelly, W. K.
    Annals of Oncology (2003)

    Fulltext@MSK | Save
  • Hepatic artery infusion for liver metastases
    Journal Article

    Kemeny, N. E.; Galsky, M.
    Seminars in Colon and Rectal Surgery (2002)

    Fulltext@MSK | Save